SCHEMBL3841663

SCHEMBL3841663

COc1ccc2c(c1)OCCn1c-2c(C2CCCCC2)c2ccc(C(=O)N[C@@H](Cc3ccc(NC(=O)O)cc3)c3csc(C)n3)cc21

nearest known ligand 0.38

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 7/20 0.38
NR1I2 O75469 5/20 0.37
CYP3A4 P08684 4/20 0.37
CYP2C19 P33261 2/20 0.37
CYP2C9 P11712 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
SCN9A Q15858 1/20 0.35
PTPRB P23467 1/20 0.35
PTPN1 P18031 1/20 0.35
SCN5A Q14524 2/20 0.35
MAPT P10636 1/20 0.34
PRKCA P17252 1/20 0.34
MMP12 P39900 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12429113 0.96 KCNH2 (0.39) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL773151 0.93 KCNH2 (0.38) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL12429109 0.93 PTPN1 (0.38) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL2203659 0.91 KCNH2 (0.38) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL772860 0.89 NR1I2 (0.38) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL3778289 0.88 KCNH2 (0.38) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL4051516 0.86 KCNH2 (0.40) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL2200713 0.84 CYP3A4 (0.44) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL10283254 0.83 KCNH2 (0.39) KCNH2NR1I2CYP3A4CYP2C19CYP2C9
SCHEMBL2201045 0.83 CYP3A4 (0.37) KCNH2NR1I2CYP3A4CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206715-A1 Fused heterotetracyclic compounds and use thereof as hcv polymerase inhibitor Japan Tobacco, Inc. (JP) 2010-07-14 EP disclosed
EP-1719773-B1 FUSED HETEROTETRACYCLIC COMPOUNDS AND USE TEHREOF AS HCV POLYMERASE INHIBITOR JAPAN TOBACCO INC (JP) 2009-04-15 EP disclosed
EP-1719773-A1 FUSED HETEROTETRACYCLIC COMPOUNDS AND USE TEHREOF AS HCV POLYMERASE INHIBITOR Japan Tobacco, Inc. (JP) 2006-11-08 EP disclosed